HL22

Product Description: HL22 is a harmaline derivative. HL22 significantly inhibits HCT116, MGC803 and MCF7 cancer cell lines, and inhibits MGC803 cell migration and monoclonal formation. The anti-cancer mechanism of HL22 is related to a variety of metabolic pathways and can be used in the study of cancer[1].

Formula: C31H34N4O2

References: [1]Liu Y, et al. Synthesis of harmaline N-9 derivatives and investigation of in vitro anticancer activity. Bioorg Med Chem Lett. 2025 Jan 13;119:130106.

Molecular Weight: 494.63

Research Area: Cancer

Target: Drug Derivative

• Artikelnummer: MEXHY-172097-0
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-172097-0
• Verpackungseinheit: Get quote
• Mengeneinheit: STK